SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-24-035022
Filing Date
2024-04-22
Accepted
2024-04-22 17:26:17
Documents
13
Period of Report
2024-04-22
Items
Item 1.03: Bankruptcy or Receivership

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0204423-8k_gamidacell.htm   iXBRL 8-K 40854
  Complete submission text file 0001213900-24-035022.txt   214942

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE gmdaq-20240422.xsd EX-101.SCH 3027
3 XBRL LABEL FILE gmdaq-20240422_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE gmdaq-20240422_pre.xml EX-101.PRE 22366
16 EXTRACTED XBRL INSTANCE DOCUMENT ea0204423-8k_gamidacell_htm.xml XML 3676
Mailing Address 5 NAHUM HAFZADI STREET JERUSALEM L3 95484
Business Address 5 NAHUM HAFZADI STREET JERUSALEM L3 95484 97226595666
Gamida Cell Ltd. (Filer) CIK: 0001600847 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38716 | Film No.: 24862138
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)